Geology more likely states:
Wisconsin
nebraska
west virginia
michigan
Incidence of MH:
1 in 100,000 Sx procedures in adults and 1 in 30,000 in children
52% all reactions are documented in children <15 yrs age
Higher in males
Pathophys of MH
Inherited disorder of skeletal muscle
DEFECT in calcium regulation that is expressed by exposure to specific anesthetic triggers (VA or Succ)
Most genetic variants are found on:
RYR1 gene (70% of cases)
- codes the ryanodine receptor
-major calcium release channel of the sarcoplasmic reticulum
VA or Succ include MH which cases the following:
Enhanced calcium release from SR - effects skeletal muscle
ELEVATED Calcium results in muscel contraction and abnormal muscle metabolism - attempted removal of calcium increases metabolism
OXYGEN consumption, CO2 production, heat production, LA production
ATP depelted
ACIDOSIS, hyperthermia, ATP depletion cause the sarcolemma to be destroyed which increases K, myoglobin and CK
Clinical manifestations of MH:
TYPICALLY occurs immediately after induction of anesthesia, but can occur several hours into the sx or even when the surgery is completed
Succ may increase the risk of MH:
20x and hasten the onset and severity of the episode
Clinical events that occur with MH
Unexplained sudden RISE in ETCO2 >55mmHg most RELIABLE sign - RISES out of proporotion to minute ventilation
Unexplained tachycardia
Masseter muscle rigidity - cant open jaw
RISING temp 1-2 C every 5 mins at an average temp of 39.3
COLA colored urine (myoglobinuria)
Decreased SaO2
Labile BP
mottled,cyanotic skin
Clinical labs with MH;
ABG - mixed resp/metabolic acidosis
SERUM K >6
CK > 20,000
Serum Myoglobin - 170mcg/L
Urine myoglobin - >60mcg/L
Blood lactate levels 10-20x
On average, how many anesthetics occur before a triggering event:
3
Qutesions to ask in preop
Any family history of unexpected intraoperative complications or deaths
Any family history of MH, muscle rigidity/stiffness, and/or high fever under anesthesia
Personal history of dark/cola colored urine after surgery/exercise
Personal or family history of high temperature or death during exercise
All fam hx must be:
Treated as MH positive
Diseases that show a genetic link to MH susceptibility:
Central core disease
King-Denborough syndrome
Multi-minicore myopathy
Managmenet of MH
Hyperventialtion provides several benefits:
facilitates CO2 elimination
Enhances O2 delivery
Drives K into cells
Treating HyperK
Hyperventilation
Calcium chloride 10mg/kg (max dose 2000mg) or calcium gluconate 30mg/kg (max dose 3000mg)
Soidum bicarb 1-2mEq/kg IV
Glucose/insulin admin 10 units regulat insulin +50mL 50% dextrose
Who can you call?
Malignant Hyperthermia Association of the United States (MHAUS) early to report the MH event; they will also walk you through steps on what to do
1-800-644-9737
Dantrolene packaged:
As 20mg vials that must be reconstituted with 60ml of sterile water for injection
EACH vial of dantrolene contains 3g of mannitol
MOA of dantrolene:
Muscle relaxant
WILL REDUCE Ca release from RYR1 receptor
WILL PREVENT Ca entry into the myocyte (REduces stimulus for calcium induced calcium release)
Requires vigorous mixing and therefore you will need multiple people to be preparing it at once so you can maintain the administration
Ryanodex is packaged as:
250mg vials and requires 5ml of sterile water diluent
EACH vial of ryanodex contains 0.125g of mannitol
If sx permits, what is preferable for MH patient:
REGIONAL or LOCAL
Amides and esters are non triggering
What should be readily available with MH:
MH kit/cart in OR
Ice and 3000mL of cold IV fluid
Trace anesthesia gas from anesthesia machine must be removed via the following:
Change out CO2 ABSORBER
REMOVE anesthetic vaporizers
FLUSH the anesthesia gas machine via 10L/min for 20-30 minutes
Attach new circuit and reservoir bag
ATTACH activated charcoal filters on insp and exp limbs of circuit